Terms ending in 2037
Every in-force patent on Genesis Intelligence, LLC's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,178,576 | Early Detection of Neurodegenerative Disease In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | |
| US 11,096,653 | Networked Electronic Stethoscope In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | |
| US 12,070,320 | Neuroanal Ytic, Neurodiagnostic, and Therapeutic Tools In force · Medium confidence | Genesis Intelligence, LLC | In force | Medium confidence | |
| US 10,799,186 | Detection Of Disease Conditions And Comorbidities In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | |
| US 11,504,038 | Early Detection of Neurodegenerative Disease In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | |
| US 11,490,851 | Neuroanalytic, Neurodiagnostic, and Therapeutic Tools In force · High confidence | Genesis Intelligence, LLC | In force | High confidence | |
| US 12,458,299 | Detection Of Disease Conditions And Comorbidities In force · High confidence | Genesis Intelligence, LLC | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.